RK
Rishi Kumar Singh
About Rishi Kumar Singh
Data last updated:
Rishi Kumar Singh is a Director at Vitaprime Pharmaceutical Private Limited (since 2024) and Director at Solis Research Private Limited (since 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vitaprime Pharmaceutical Private Limited U46497UP2024PTC210487 | Director | 11 Oct 2024 | 2024 | Active | |
| Solis Research Private Limited U66309UP2023PTC192912 | Director | 22 Nov 2023 | 2023 | Active |
Board colleagues of Rishi Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rashmi Singh | 10806234 | Vitaprime Pharmaceutical Private Limited | Managing Director |
| Atul Kumar Singh | 10401640 | Solis Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishi Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishi Kumar Singh
Rishi Kumar Singh currently holds 2 directorships: Vitaprime Pharmaceutical Private Limited (Director, since 11 Oct 2024); Solis Research Private Limited (Director, since 22 Nov 2023).
Rishi Kumar Singh was first appointed on 22 Nov 2023 as Director at Solis Research Private Limited. The most recent appointment on record is 11 Oct 2024 at Vitaprime Pharmaceutical Private Limited.
The current boards of Rishi Kumar Singh's companies include Rashmi Singh (Vitaprime Pharmaceutical Private Limited), Atul Kumar Singh (Solis Research Private Limited).